glp-1 injection pen Who Should Explore Shots from BodyLogicMD? GLP-1s and PMOS: PCOS, Insulin

Studies by Ogata et al

Developed by Metabolic Pharmaceuticals in Australia, AOD-9604 was engineered to retain the fat-reducing properties of intact growth hormone while eliminating the undesirable effects on glucose metabolism, insulin sensitivity, and tissue growth

The primary endpoints were change in TB-score at 24 weeks and culture conversion at 8 weeks

(More information) Both depression and osteoporosis have been linked to diminished vitamin B 12 status and high homocysteine levels

No long-term or CV safety data

SS-31 has dimethyl tyrosine residues that interact with oxygen radicals forming unreactive tyrosine radicals